Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Biogen Idec Becomes Biogen

March 23, 2015 8:15 am | News | Comments

Effective today, Biogen Idec is known simply as Biogen. The company has introduced a new corporate identity and logo that reflect both its evolution and focus on bringing forth new therapies in areas of high unmet needs.

TOPICS:

Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab

March 23, 2015 8:07 am | News | Comments

Pfizer and Eli Lilly announced today that they are preparing to resume the Phase 3 clinical program for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with their collaboration agreement.

TOPICS:

FDA Panel Backs Glaxo Inhaler for Adults, Not Adolescents

March 20, 2015 8:39 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents.

TOPICS:
Advertisement

Texas Ready to Dump High School Steroids Testing Program

March 20, 2015 8:31 am | by JIM VERTUNO, AP Sports Writer | News | Comments

When Texas officials launched a massive public high school steroids testing program over fears of rampant doping from the football fields to the tennis courts, they promised a model program for the rest of the country to follow. But almost no one did.

TOPICS:

Officials Urge Meningitis Shots at University of Oregon

March 20, 2015 8:27 am | by JEFF BARNARD, Associated Press | News | Comments

More than half of the undergraduates at the University of Oregon have not been vaccinated against meningitis, despite the fact that one student has died and five others have been sickened since January.

TOPICS:

Emails: World Health Organization Resisted Declaring Ebola Emergency

March 20, 2015 8:20 am | by MARIA CHENG, Associated Press; RAPHAEL SATTER, Associated Press | News | Comments

In a delay that some say may have cost lives, the World Health Organization resisted calling the Ebola outbreak in West Africa a public health emergency until last summer, two months after staff raised the possibility and long after a senior manager called for a drastic change in strategy.

TOPICS:

Coronado Biosciences Announces the Formation of Mustang Therapeutics

March 20, 2015 8:17 am | News | Comments

Coronado Biosciences has announced the formation of a new company, Mustang Therapeutics, Inc. Mustang will initially focus on the preclinical and clinical development, as well as commercialization of proprietary Chimeric Antigen Receptor (CAR-T) technology.

TOPICS:

Biogen Idec Releases Alzheimer's Drug Data

March 20, 2015 8:07 am | by The Associated Press | News | Comments

Biogen Idec released much anticipated results from a study of a potential Alzheimer's disease treatment on Friday, showing that it slowed cognitive decline in some patients.

TOPICS:
Advertisement

Evotec and Sanofi Sign Agreement for Major Multi-Component Strategic Alliance

March 20, 2015 8:05 am | News | Comments

Evotec AG today announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi. The transaction is expected to close on 31 March 2015.

TOPICS:

Pharmaceutical, Biotech Mergers Set Record in 2014

March 19, 2015 1:42 pm | by Andy Szal, Digital Reporter | News | Comments

Mergers and acquisitions in the pharmaceutical and biotechnology sectors set a record in 2014, according to a report by Evaluate Ltd.

TOPICS:

Analyst: Big Pharma Should Increase Investments in Alzheimer’s, Parkinson’s

March 19, 2015 10:14 am | by Andy Szal, Digital Reporter | News | Comments

Improved coordination between researchers and pharmaceutical companies could help bolster development of treatments for neurodegenerative diseases such as Alzheimer's or Parkinson's, according to an industry analyst.

TOPICS:

Boehner, Pelosi See Victories in Fixing Medicare Doctors' Fees

March 19, 2015 8:42 am | by ALAN FRAM, Associated Press | News | Comments

An uncharacteristic joint effort by House Speaker John Boehner and his usual nemesis, Minority Leader Nancy Pelosi, to resolve a gnawing problem about how Medicare pays doctors underscores the political victories each sees in finally sweeping the issue off the deck — if they can.

TOPICS:

Study: Prevnar Vaccine Slashed Serious Infections in Elderly

March 19, 2015 8:33 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

A huge study of Pfizer's blockbuster vaccine against pneumonia and other bacterial infections in adults 65 and older found it protected most of them against dangerous infections in the bloodstream and other sterile body areas.

TOPICS:

Daiichi Sankyo Signs Agreement with AstraZeneca to Co-Commercialize MOVANTIK in the US

March 19, 2015 8:18 am | News | Comments

Under the terms of the agreement, Daiichi Sankyo will pay a $200M up-front fee and subsequent sales-related payments of up to $625M. AstraZeneca will be responsible for manufacturing, will book all sales and will make sales-related commission payments to Daiichi Sankyo.

TOPICS:

Report: U.S. Market for Asthma Treatment to See Modest Growth

March 19, 2015 8:09 am | by Andy Szal, Digital Reporter | News | Comments

The analysis by New York-based GBI Research predicted the recent expiration of patents for several of the top current therapeutics--most notably Singulair, Advair and Symbicort--would allow generic versions to curb market growth.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading